My daily Thoughts
All these academics saying the have tests (Stanford, Mayo Clinic) is a nice PR for them but can anyone identify how they are going to produce enough to be off any use? Again this is about getting enough into the population to make a difference. Not coming up up the best test in the lab!
Everyone is now starting to see the logic in antibody testing, pred were a month ahead of the curve and are now best placed to answer the demand.
No other group I’m aware off have the ability to validate the test to the standard needed to get the point of care EUA which I’d expect this week. Saying that, it’s not even needed but it’s nice to have.
Demand will exceed supply by a factor of 10x .
Re capacity, DABLOOD and pred we very specific in saying they needed to ramp up 1.5m per day. They are not there yet. I suspect the capacity at present is around 2m per week and growing from there.
If it’s only 2m per week and they only make $10 per testkit, that’s $20m per week. Anyone unhappy with that!!
$80m per month .
I suspect it will be much more but just using numbers on the low side for perspective.
The first orders will tell the tale.
If it’s more than 100k then we will go parabolic on the stock. 500k to 1m would be amazing.
All is well, pred is on a great place. All the other competition have problems, can’t get out of China, can’t validate in US as they aren’t a lab, don’t have distribution partners like preds, and much more.
Pred are doing everything right at present, I’d expect that to continue this week.
See you at $20
Oh and almost forgot!! Number 1 stemcell lab in the country so who knows what happens there !!
See you at $40
